BRIMOCHOL Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for BRIMOCHOL with the United States Patent and Trademark Office. The USPTO has given the BRIMOCHOL trademark a serial number of 88900290. The federal status of this trademark filing is REGISTERED as of Tuesday, June 21, 2022. This trademark is owned by Visus Therapeutics Inc.. The BRIMOCHOL trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic drugs
brimochol

General Information

Serial Number88900290
Word MarkBRIMOCHOL
Filing DateMonday, May 4, 2020
Status700 - REGISTERED
Status DateTuesday, June 21, 2022
Registration Number6768713
Registration DateTuesday, June 21, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesOphthalmic drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 16, 2020
Primary Code005
First Use Anywhere DateWednesday, April 14, 2021
First Use In Commerce DateWednesday, April 14, 2021

Trademark Owner History

Party NameVisus Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameVisus Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109
Party NameVisus Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events

Event DateEvent Description
Monday, July 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 21, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 21, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, May 14, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 13, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 12, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 3, 2022USE AMENDMENT FILED
Thursday, May 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 3, 2022TEAS STATEMENT OF USE RECEIVED
Friday, October 29, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 29, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 29, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 22, 2021SOU EXTENSION 2 GRANTED
Friday, October 22, 2021SOU EXTENSION 2 FILED
Friday, October 22, 2021TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 3, 2021SOU EXTENSION 1 GRANTED
Monday, May 3, 2021SOU EXTENSION 1 FILED
Monday, May 3, 2021TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 29, 2020ASSIGNED TO EXAMINER
Saturday, May 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 7, 2020NEW APPLICATION ENTERED

Related Keywords

brimochol drugs ophthalmic